Clik here to view.
Mazor Robotics gains on Street-beating Q4 outlook
Mazor Robotics (NSDQ:MZOR) said today that it expects its 4th-quarter revenues to top expectations on Wall Street, sending share prices up in mid-day trading. The Caesarea, Israel-based robot-assisted...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for January 5, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Lombard wins Japanese clearance for IntelliFlex LP delivery device for Aorfix...
Lombard Medical Technologies (NSDQ:EVAR) said today it won approval from the Japanese Ministry of Health, Labour and Welfare for its Intelliflex low profile delivery system for the Aorfix endovascular...
View ArticleClik here to view.
Boston Sci giving lift to new erectile dysfunction device
[Image courtesy of University of Wisconsin]Want to put some lead in your pencil? Try nitinol instead. The wonder metal—a nickel-titanium alloy with heat-activated shape memory—has proved essential for...
View ArticleClik here to view.
Terumo, Xenex ink Japanese distro deal for LightStrike room disinfection robot
Terumo Corp. (TYO:4543) said today it inked a Japanese distribution deal with Xenex to distribute its Xenex LightStrike Germ-Zapping Robots in the region. The LightStrike device is designed to use...
View ArticleClik here to view.
Axonics wins Health Canada nod for rechargeable sacral neuromod system
Axonics Modulation Technologies said today it won Health Canada approval for its rechargeable Sacral Neuromodulation System designed to treat overactive bladder, fecal incontinence and urinary...
View ArticleClik here to view.
NeuroMetrix closes $7m private offering
NeuroMetrix (NSDQ:NURO) said today it closed a private placement round, bringing in a total of $7 million to support the commercialization of its Quell wearable pain relief device. The Waltham,...
View ArticleClik here to view.
SV Life Sciences gets in on ‘significant’ round for Bardy Diagnostics
Healthcare investor SV Life Sciences joined a ‘significant round of growth capital’ for medtech developer Bardy Diagnostics and its Carnation cardiac monitor and arrhythmia detection device. The...
View ArticleClik here to view.
Emergo: Top 10 medical device regulatory stories of 2016
By Stewart Eisenhart, Emergo Group At the start of a new year, Emergo takes a look back at what we believe were some of the most important developments of 2016 for the medical device regulatory field...
View ArticleClik here to view.
Taris Biomedical closes enrollment in phase Ib trial for drug-device combo
Taris Biomedical said today that it closed initial enrollment in its phase Ib clinical trial following positive results. The study is evaluating the safety and efficacy of its drug-device combination...
View ArticleClik here to view.
Globus Medical wins CE Mark for Excelsius GPS robotic guidance device
Globus Medical (NYSE:GMED) said today that it won CE Mark approval in the European Union for the Excelsius GPS robotic guidance device it acquired 3 years ago. Audubon, Pa.-based Globus said the...
View ArticleClik here to view.
Owlstone Medical raises $11.6m for disease breathalyzer device
Owlstone Medical said today that it raised $11.6 million to help fund its disease breathalyzer device. The round was led by existing investors and follows an original investment of $7 million that spun...
View ArticleClik here to view.
Pfizer agrees to $100m haircut in Hospira infusion sale to ICU Medical
Pfizer (NYSE:PFE) has agreed to take a $100 million hit on its previously $1 billion sale of its Hospira infusion pump business to ICU Medical (NSDQ:ICUI), bringing in approximately $900 million. The...
View ArticleClik here to view.
Invuity shares lift on Street-topping Q4, FY2016 prelims
Invuity (NSDQ:IVTY) today released preliminary Q4 and full year 2016 earnings, topping the Street’s estimates and sending its shares up slightly in mid day trading. The San Francisco-based company said...
View ArticleClik here to view.
Celsion’s ThermoDox activated by ultrasound in pediatric cancer study
Celsion (NSDQ:CLSN) and Children’s National Health System are teaming up to tackle refractory solid tumors in pediatric patients using a heat-activated chemotherapy drug and noninvasive ultrasound. The...
View ArticleClik here to view.
Avinger shares drop on Q4 prelims
Avinger (NSDQ:AVGR) saw shares prices drop -12% today after it released preliminary financial results for the 4th quarter, missing analysts’ expectations on Wall Street. The Redwood City, Calif.-based...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for January 6, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
AngioDynamics posts Q2 earnings
Shares in AngioDynamics (NSDQ:ANGO) rose today after the medical device maker met expectations on Wall Street with its fiscal 2nd quarter results. The Albany, N.Y.-based company posted profits of $45...
View ArticleClik here to view.
Senseonics prelim beat Q4 estimates
Senseonics (NYSE:SENS) saw shares rise 5.6% today after it released preliminary financial results for the 4th quarter, beating analysts’ expectations on Wall Street. The Germantown, Md.-based company...
View ArticleClik here to view.
Hatteras Venture Partners raises $150m for 5th life sciences fund
Medical-focused Hatteras Venture Partners said today it closed its 5th life sciences fund, the Hatteras Venture Partners V fund, with over $150 million in capital. The group said it aims to use the...
View Article
